Trial Search Results

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

The purpose of this study is to determine what combinations of anti-HIV drugs work best in patients treated over several years. The study will also assess the occurrence of side effects and opportunistic infections in patients with low viral loads compared to those with higher viral loads.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

AIDS Clinical Trials Group

Collaborator: National Institute of Allergy and Infectious Diseases (NIAID)

Stanford Investigator(s):


Inclusion Criteria

   - HIV-1 infected

   - Enrolled in an AIDS Clinical Trial Group (ACTG) parent study and has enrolled in this
   study on or before the Week 16 visit of the parent study, including the visit window
   of the parent study. More information on this criterion can be found in the protocol.

   - Willing to provide consent for the release and use of clinical data from the parent

   - Life expectancy of at least 24 weeks

   - Parent or guardian willing to provide informed consent, if applicable

Exclusion Criteria

   - Active alcohol or drug abuse that may interfere with the study

Ages Eligible for Study

13 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Debbie Slamowitz
Not Recruiting